Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

398 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.
Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y, Ikeda S, Masuda M, Nagoshi H, Ueda R, Tamura K, Sano M, Momita S, Yamaguchi K, Kawano F, Hanada S, Tobinai K, Shimoyama M, Hotta T, Tomonaga M; Japan Clinical Oncology Group Study JCOG9801. Tsukasaki K, et al. Among authors: utsunomiya a. J Clin Oncol. 2007 Dec 1;25(34):5458-64. doi: 10.1200/JCO.2007.11.9958. Epub 2007 Oct 29. J Clin Oncol. 2007. PMID: 17968021 Clinical Trial.
Arsenic trioxide induces apoptosis in HTLV-I infected T-cell lines and fresh adult T-cell leukemia cells through CD95 or tumor necrosis factor alpha receptor independent caspase activation.
Ishitsuka K, Ikeda R, Utsunomiya A, Uozumi K, Hanada S, Suzuki S, Takeuchi S, Takatsuka Y, Takeshita T, Ohno N, Arima T. Ishitsuka K, et al. Among authors: utsunomiya a. Leuk Lymphoma. 2002 May;43(5):1107-14. doi: 10.1080/10428190290021461. Leuk Lymphoma. 2002. PMID: 12148893
Campylobacter fetus bacteremia in a patient with adult T cell leukemia.
Chuman Y, Takata T, Sameshima H, Takeuchi S, Takatsuka Y, Makino T, Blaser MJ, Utsunomiya A. Chuman Y, et al. Among authors: utsunomiya a. Clin Infect Dis. 2003 Jun 1;36(11):1497-8. doi: 10.1086/374874. Clin Infect Dis. 2003. PMID: 12766848 No abstract available.
Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: a Japan clinical oncology group study, JCOG 9301.
Takenaka T, Itoh K, Suzuki T, Utsunomiya A, Matsuda S, Chou T, Sai T, Sano M, Konda S, Ohno T, Mikuni C, Deura K, Yamada T, Mizorogi F, Nagoshi H, Tomonaga M, Hotta T, Kawano K, Tsushita K, Hirano M, Shimoyama M; Lymphoma Study Group of the Japan Clinical Oncology Group. Takenaka T, et al. Among authors: utsunomiya a. Int J Hematol. 2004 Feb;79(2):165-73. doi: 10.1532/ijh97.03115. Int J Hematol. 2004. PMID: 15005346 Clinical Trial.
Adult T-cell leukemia: future prophylaxis and immunotherapy.
Kannagi M, Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Masuda M. Kannagi M, et al. Among authors: utsunomiya a. Expert Rev Anticancer Ther. 2004 Jun;4(3):369-76. doi: 10.1586/14737140.4.3.369. Expert Rev Anticancer Ther. 2004. PMID: 15161436 Review.
Phase I study of the combination of irinotecan hydrochloride, carboplatin, and dexamethasone for the treatment of relapsed or refractory malignant lymphoma.
Suzumiya J, Suzushima H, Maeda K, Okamura S, Utsunomiya A, Shibuya T, Tamura K; Kyushu Hematology Organization for Treatment Study Group. Suzumiya J, et al. Among authors: utsunomiya a. Int J Hematol. 2004 Apr;79(3):266-70. doi: 10.1532/ijh97.03071. Int J Hematol. 2004. PMID: 15168596 Clinical Trial.
398 results